Osilodrostat, a potent oral 11β-hydroxylase inhibitor: 22-week, prospective, Phase II study in Cushing’s disease
Titel:
Osilodrostat, a potent oral 11β-hydroxylase inhibitor: 22-week, prospective, Phase II study in Cushing’s disease
Auteur:
Fleseriu, Maria Pivonello, Rosario Young, Jacques Hamrahian, Amir H. Molitch, Mark E. Shimizu, Chikara Tanaka, Tomoaki Shimatsu, Akira White, Tracy Hilliard, Annie Tian, Chuan Sauter, Nicholas Biller, Beverly MK Bertagna, Xavier